Stephen is an associate at Troutman Sanders in the Corporate Practice Group. His practice focuses on the representation of public and private companies in connection with mergers and acquisitions, securities offerings and other complex business transactions.  Stephen's responsibilities include advising senior executives and directors with respect to general corporate matters, including ongoing securities compliance and corporate governance issues.

Stephen received his B.A. in History from the University of Maryland, Baltimore County, in 2001.  In 2008, he received his J.D. from the Washington and Lee University School of Law.  Stephen served as a summer law clerk to The Honorable Paul M. Peatross, Jr., Circuit Court of Albemarle County in Charlottesville, Virginia.

Representative Experience
Advisor to issuers and underwriters in connection with FINRA Corporate Financing Department filings.

Represented a NASDAQ-listed telecommunications company in connection with the spin-off of its $300 million wireline communications business into a new publicly traded company.

Represented a global investment bank as underwriter's counsel in connection with the public offering of up to 10,000,000 shares of common stock for a NASDAQ-listed business development company.

Represented a distribution agent in connection with the shelf takedown registration and at-the-market offering of up to 1,600,000 shares of common stock for NYSE Amex Equities-listed, non-diversified, closed-end management investment company investing primarily in Chilean securities.

Represented a distribution agent in connection with the shelf takedown registration and at-the-market offering of up to 3,300,000 shares of common stock for NYSE Amex-listed, non-diversified, closed-end management investment company primarily investing primarily in Australian equity securities.

Represented a leading investment bank as underwriter's counsel in connection with the public offering of up to 9,000,000 shares of common stock for a NASDAQ-listed business development company.

Represented a NYSE-listed coal company in connection with its $7.1 billion sale to the largest producer of metallurgical coal in the United States.

Represented several broker-dealers in connection with the purchase of $150 million in senior convertible notes from a NASDAQ-listed business development company.

Represented a local children's hospital in connection with its joint operations with Virginia Commonwealth University Health System to form Children's Hospital of Richmond.

Represented a NASDAQ-listed telecommunications company in connection with its $170 million purchase of a fiber network unit.

Represented a distribution agent in connection with the public offering of up to 8,000,000 shares of common stock for a NASDAQ-listed business development company.

Represented a NYSE-listed coal company in connection with its $960 million acquisition of one of the largest privately held coal producers in the United States.

Represented a sole book-running manager in connection with the public offering of 805,000 shares of common stock for a NYSE Amex-listed, non-diversified, closed-end management investment company.

Represented a distribution agent in connection with the shelf takedown registration and at-the-market offering of up to 1,000,000 shares of common stock for NYSE- and NYSE Amex-listed, non-diversified, closed-end management investment companies.

Represented a private equity fund in a PIPE transaction in which it purchased $15 million of common stock and warrants from a NASDAQ-traded organic fertilizer company.

Represented a NYSE-listed security services company in connection with its purchase of a majority stake in a Hong Kong-based security services firm.

Represented a private equity fund in a PIPE transaction in which it purchased $50 million of convertible notes and warrants from a NASDAQ-traded global biotechnology company.

Represented a NYSE-listed U.S. energy holding company in connection with a $100 million term loan credit agreement.

Represented a NYSE-listed packaging solutions provider in connection with its purchase of a majority stake in an Indian manufacturing company.

Represented a NYSE-listed U.S. specialty chemical company in connection with the reorganization of its subsidiaries and branch offices in jurisdictions throughout the world.